Sandler Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-75,000
Closed -$3.81M 127
2021
Q4
$3.81M Buy
+75,000
New +$3.33M 0.33% 82
2020
Q2
Sell
-209,000
Closed -$4.57M 99
2020
Q1
$4.57M Buy
+209,000
New +$6.29M 0.63% 61
2019
Q3
Sell
-250,000
Closed -$12.3M 141
2019
Q2
$12.3M Buy
250,000
+100,000
+67% +$5.09M 0.82% 48
2019
Q1
$7.18M Buy
+150,000
New +$9.09M 0.56% 72
2017
Q2
Sell
-203,500
Closed -$11.3M 184
2017
Q1
$11.3M Buy
+203,500
New +$10.5M 0.78% 32
2014
Q1
Sell
-200,000
Closed -$27.6M 221
2013
Q4
$27.6M Buy
200,000
+90,000
+82% +$10.6M 0.9% 36
2013
Q3
$10.5M Buy
+110,000
New +$9.34M 0.33% 113

Other funds holding NUS

Sandler Capital Management's NUS Position: Q2 2014 in Review

Sandler Capital Management sold out of Nu Skin (NUS) in Q2 2014, closing a stake of 100,000 shares — an estimated $8.29M sold.

Sandler Capital Management first reported a position in NUS in Q3 2013 and held it in 2 quarters. The position peaked at $14.6M in Q3 2013. 267 funds tracked by Wall St. Rank hold NUS as of Q2 2014.

  • Sandler Capital Management reported no remaining Nu Skin position as of Q2 2014 after selling out during the quarter.
  • Sandler Capital Management sold 100,000 Nu Skin shares in Q2 2014, an estimated $8.29M.
  • Sandler Capital Management first reported a position in Nu Skin in Q3 2013 and held it in 2 quarters.
  • Sandler Capital Management's Nu Skin position peaked at $14.6M in Q3 2013.
  • 267 funds tracked by Wall St. Rank held Nu Skin as of Q2 2014.

Based on Sandler Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.